Pharmaceutical News and Articles

Spinogenix Completes Phase 2 Study of SPG601 for Treatment of Fragile X Syndrome, a Common Inherited Form of Autism, Showing Strong Efficacy Signal in Measures of Abnormal Brain Activity

LOS ANGELES, Calif., February 11, 2025 Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore synapses

FDA Approves Genentech’s Evrysdi Tablet as First and Only Tablet for Spinal Muscular Atrophy (SMA)

Senators Call on FDA to Act Against Misleading Weight-Loss Drug Commercials

Commercials run by the telehealth company Hims Hers have been placed under the microscope as lawmakers are calling out advertisement of prescription of injectab

Federal Judge Rules FDA, CDC Must Restore Health Websites Removed Under Trump Order

A federal judge has ordered the U.S. Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) to restore access to public health

More Evidence Ozempic Can Curb Alcoholism

Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb their intake. The research found that, compar

Almost Half of Rural Americans Face Long Drives for Surgery

As closures of rural hospitals across the United States continue, more Americans are facing hour-plus drives to reach surgical centers, two new reports find. By

Canned Tuna Recalled in Dozens of State Over Risk of Food Poisoning

A major recall of canned tuna sold in dozens of states has been issued amid concerns that a packaging defect could cause a potentially fatal form of food poison

In People With Autism, ADHD Rates Still Common in Adulthood

Too often, ADHD and autism coincide in children. New research finds that for many of those kids, this dual diagnosis continues into adult life. Having attention

Lithium Linked to Risk for Thyroid Dysfunction, CKD in Bipolar Disorder

Lithium is associated with an increased risk for thyroid dysfunction and chronic kidney disease (CKD) in patients with incident bipolar disorder (BD), according

In 2023, 1.4 Percent of U.S. Children Ever Experienced Post-COVID Condition

Post-COVID condition (PCC) continues to affect children, and 80 percent of those currently experiencing PCC have activity limitation, according to a research le